Description:

ODM derived from http://clinicaltrials.gov/show/NCT00327379

Link:

http://clinicaltrials.gov/show/NCT00327379

Keywords:
Versions (1) ▾
  1. 12/11/13
Uploaded on:

December 11, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00327379 Postoperative Hemorrhage

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion Criteria
Age 18 Years and older
Subjects requiring elective spinal fusion surgery involving 3 to 7 vertebral levels with instrumentation. One vertebral level is defined as encompassing two vertebral bodies and one inter-vertebral disc space, so that a contiguous spinal fusion involving 3 vertebral levels would include 4 vertebral bodies and 3 inter-vertebral disc spaces.
Exclusion Criteria
Subjects with previous exposure to aprotinin in the last 6 months. If the subject has undergone cardiac surgery in the last 6 months, all attempts should be made to ascertain if aprotinin was administered during cardiac surgery. If no records are available, or if the subject received aprotinin, the subject should be excluded.
Subjects with a known or suspected allergy to aprotinin.
Subjects with sepsis or a known bone infection.
Personal history of malignant neoplasm of bone
Subjects with a creatinine clearance <30mL/min as calculated by the Cockcroft-Gault formula.
Subjects with a history of bleeding diathesis or known coagulation factor deficiency.
Subjects with failure of a major organ system or any active significant medical illness that in the opinion of the Investigator is likely to affect the subject's ability to complete the study or precludes the subject's participation in the study.
Subjects who refuse to receive allogenic blood products for religious or other reasons.
Subjects whose preoperative red blood cell volume is so low that a blood transfusion would be likely to be given perioperatively (preoperative hematocrit or hemoglobin values <24% or <8 g/dl, respectively).
Subjects who have participated in an investigational drug study within the past 30 days.
Subjects with a history of deep vein thrombosis or pulmonary embolism.
Subjects who are pregnant or breast feeding.
Women of childbearing potential in whom the possibility of pregnancy cannot be excluded by a negative serum pregnancy test at screening.
Women of childbearing potential who are not using a reliable method of contraception.
Antifibrinolytic Agents
Subjects on chronic anticoagulant treatment with Vit K antagonists that cannot be temporarily discontinued for the surgical procedure (as per local practices).